Scott Colquhoun, MD
Orthopaedic Surgery · Turlock, CANPI 1144200692
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (39.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 85.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $10,322 and has fallen 75.5% since, to $2,525 in 2025.
Across 262 payments — averaging $83.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$19K
- Amgen$2K
- Pacira Pharmaceuticals Incorporated$503
- Pacira Therapeutics, Inc.$416
- Stryker$226
- Heron Therapeutics, Inc.$133
- plus $422 from 10 others
What the payments were for
- Consulting fees$6,16728%
- Travel & lodging$8,54839%
- Food & beverage$7,11233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 71 | $18,549 |
| Amgen(2 entities) | 109 | $1,578 |
| Pacira Pharmaceuticals Incorporated | 14 | $503 |
| Pacira Therapeutics, Inc. | 37 | $416 |
| Stryker | 7 | $226 |
| Heron Therapeutics, Inc. | 4 | $133 |
| Zimmer Biomet | 1 | $95 |
| Sanofi-aventis U.S. LLC | 4 | $66 |
| Cornerstone Medical Associates, Inc. | 3 | $57 |
| Boston Scientific | 1 | $46 |
| Fidia Pharma USA Inc. | 2 | $43 |
| Bioventus LLC | 2 | $34 |
| Avanos Medical | 1 | $25 |
| Orthofix Medical, Inc. | 4 | $21 |
| Endo USA, Inc. | 1 | $21 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Navio Surgical System$8,702
- Journey II$5,437
- RI.HIP NAVIGATION$3,425
- JOURNEY$3,425
- REAL INTELLIGENCE$3,226
- Legion Revision$3,057
- OR3O Dual Mobility$2,240
- POLARSTEM$2,071
- REDAPT$2,021
- Tandem$1,639
- Journey II CR$981
- Bioinductive Implant with Arthroscopic Delivery System - Medium$950
- Journey II XR$867
- TWINFIX$508
- AETOS Shoulder System$508
- VISIONAIRE$381
- Legion$381
- Firstpass$365
- REDAPT Revision Hip System$267
- Q-FIX$250
How this compares
$21,826 in reported general payments places this provider in the 80th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 273 | $11,373 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 169 | $1,932 |
| Gabapentin | 224 | $1,721 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 82 | $638 |
| Ondansetron Hcl | 128 | $516 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 98 | $198 |
| Tramadol Hcl | 52 | $152 |
| Amoxicillin | 74 | $115 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 15 | $97 |
| Meloxicam | 35 | $59 |
| Clindamycin Hcl | 23 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Turlock
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.